Investor Relations Home - Achieve Life Sciences

Investors Home

Home 2017-06-16T21:39:52+00:00

Investors Home

Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.

Click here to access our latest corporate presentation.

 

Stock Info

Recent Press Releases

Recent News
Sep 15, 2021

SEATTLE, Wash and VANCOUVER, British Columbia, September 15, 2021 -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...

Sep 14, 2021

SEATTLE, Wash. and VANCOUVER, British Columbia, September 14, 2021 - Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...

Sep 9, 2021

SEATTLE, Wash and VANCOUVER, British Columbia, September 9, 2021 -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...